Literature DB >> 22232096

How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?

Mohammed K Ali1, Justin Echouffo-Tcheugui, David F Williamson.   

Abstract

We conducted a systematic review and meta-analysis of twenty-eight US-based studies applying the findings of the Diabetes Prevention Program, a clinical trial that tested the effects of a lifestyle intervention for people at high risk for diabetes, in real-world settings. The average weight change at twelve months after the intervention was a loss of about 4 percent from participants' baseline weight. Change in weight was similar regardless of whether the intervention was delivered by clinically trained professionals or lay educators. Additional analyses limited to seventeen studies with a nine-month or greater follow-up assessment showed similar weight change. With every additional lifestyle session attended, weight loss increased by 0.26 percentage point. We conclude that costs associated with diabetes prevention can be lowered without sacrificing effectiveness, using nonmedical personnel and motivating higher attendance at program sessions.

Entities:  

Mesh:

Year:  2012        PMID: 22232096     DOI: 10.1377/hlthaff.2011.1009

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  242 in total

Review 1.  Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review.

Authors:  Thomas A Wadden; Meghan L Butryn; Patricia S Hong; Adam G Tsai
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  Translating research into evidence-based practice with potential for population-wide impact.

Authors:  Matt Longjohn; Deneen Vojta
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

3.  Diabetes Prevention and Management: The Thrill Is Not Gone.

Authors:  Ann Albright
Journal:  Diabetes Spectr       Date:  2014-02

Review 4.  Behavioral interventions for obesity in children and adults: Evidence base, novel approaches, and translation into practice.

Authors:  Denise E Wilfley; Jacqueline F Hayes; Katherine N Balantekin; Dorothy J Van Buren; Leonard H Epstein
Journal:  Am Psychol       Date:  2018-11

Review 5.  Roles, responsibilities and characteristics of lay community health workers involved in diabetes prevention programmes: A systematic review.

Authors:  Jillian Hill; Nasheeta Peer; Brian Oldenburg; Andre Pascale Kengne
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

6.  Barriers and Facilitators to Real-world Implementation of the Diabetes Prevention Program in Large Healthcare Systems: Lifestyle Coach Perspectives.

Authors:  Meghan C Halley; John Petersen; Catherine Nasrallah; Nina Szwerinski; Robert Romanelli; Kristen M J Azar
Journal:  J Gen Intern Med       Date:  2020-04-06       Impact factor: 5.128

7.  Longitudinal Patterns of Stages of Change for Exercise and Lifestyle Intervention Outcomes: An Application of Latent Class Analysis with Distal Outcomes.

Authors:  Luohua Jiang; Shuai Chen; Ben Zhang; Janette Beals; Christina M Mitchell; Spero M Manson; Yvette Roubideaux
Journal:  Prev Sci       Date:  2016-04

8.  Cost-effectiveness of a faith-based lifestyle intervention for diabetes prevention among African Americans: A within-trial analysis.

Authors:  Elizabeth C Rhodes; Eeshwar K Chandrasekar; Shivani A Patel; K M Venkat Narayan; Thomas V Joshua; Lovoria B Williams; Lucy Marion; Mohammed K Ali
Journal:  Diabetes Res Clin Pract       Date:  2018-09-28       Impact factor: 5.602

9.  Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial.

Authors:  Jun Ma; Peg Strub; Lan Xiao; Philip W Lavori; Carlos A Camargo; Sandra R Wilson; Christopher D Gardner; A Sonia Buist; William L Haskell; Nan Lv
Journal:  Ann Am Thorac Soc       Date:  2015-01

10.  Diabetes Prevention Program community outreach: perspectives on lifestyle training and translation.

Authors:  Elizabeth M Venditti; M Kaye Kramer
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.